Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma

被引：1
|
作者：
Jackson, David [1 ,2 ]
Roxas, Cris [1 ]
Thompson, Louise [1 ]
Fernandes, Mariana [1 ]
Green, Linda [1 ]
Kavanagh, Joanne [1 ]
Nanzer-Kelly, Alexandra [1 ]
D'Ancona, Grainne [1 ]
Kent, Brian [1 ]
机构：
[1] Guys & St Thomas NHS Trust, Guys Severe Asthma Ctr, London, England
[2] Kings Coll London, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; Severe asthma; Exacerbation;
D O I：
10.1183/13993003.congress-2019.PA2527
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2527
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study
    Padilla-Galo, Alicia
    Carmona, Isabel Moya
    Ausin, Pilar
    Fernandez, Luis Carazo
    Garcia-Moguel, Ismael
    Velasco-Garrido, Jose Luis
    Andujar-Espinosa, Ruben
    Casas-Maldonado, Francisco
    Martinez-Moragon, Eva
    Rivera, Carlos Martinez
    Solsona, Elisabet Vera
    Lopez, Fernando Sanchez-Toril
    Alonso, Andrea Trisan
    Aparicio, Marina Blanco
    Valverde-Monge, Marcela
    Azcona, Borja Valencia
    Cervera, Marta Palop
    Nuevo, Javier
    Tena, Jesus Sanchez
    Resler, Gustavo
    Luzon, Elisa
    Naon, Alberto Levy
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [32] Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
    Kayser, Moritz Z.
    Drick, Nora
    Milger, Katrin
    Fuge, Jan
    Kneidinger, Nikolaus
    Korn, Stephanie
    Buhl, Roland
    Behr, Juergen
    Welte, Tobias
    Suhling, Hendrik
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 863 - 871
  • [33] Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE
    Panettieri Jr, Reynold A.
    Lugogo, Njira
    Moore, Wendy C.
    Chipps, Bradley E.
    Jepson, Brett
    Zhou, Wenjiong
    Ambrose, Christopher S.
    Genofre, Eduardo
    Carstens, Donna D.
    RESPIRATORY MEDICINE, 2023, 216
  • [34] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study
    Alicia Padilla-Galo
    Isabel Moya Carmona
    Pilar Ausín
    Luis Carazo Fernández
    Ismael García-Moguel
    José Luis Velasco-Garrido
    Rubén Andújar-Espinosa
    Francisco Casas-Maldonado
    Eva Martínez-Moragón
    Carlos Martínez Rivera
    Elisabet Vera Solsona
    Fernando Sánchez-Toril López
    Andrea Trisán Alonso
    Marina Blanco Aparicio
    Marcela Valverde-Monge
    Borja Valencia Azcona
    Marta Palop Cervera
    Javier Nuevo
    Jesús Sánchez Tena
    Gustavo Resler
    Elisa Luzón
    Alberto Levy Naon
    Respiratory Research, 24
  • [35] Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
    Campisi, Raffaele
    Nolasco, Santi
    Pelaia, Corrado
    Impellizzeri, Pietro
    D'Amato, Maria
    Portacci, Andrea
    Ricciardi, Luisa
    Scioscia, Giulia
    Crimi, Nunzio
    Scichilone, Nicola
    Barbaro, Maria Pia Foschino
    Pelaia, Girolamo
    Carpagnano, Giovanna Elisiana
    Vatrella, Alessandro
    Crimi, Claudia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [36] Real-world Evidence of Benralizumab in Patients With Severe Eosinophilic Asthma and Nasal Polyps: Initial Results of the RANS Study
    Le, T.
    Emmanuel, B.
    Kwiatek, J.
    Tran, T. N.
    Cohen, D.
    Kreindler, J. L.
    Katial, R.
    Daniel, S.
    Cao, Y.
    Shih, V.
    Gil Melcon, M.
    Devouassoux, G.
    Pelaia, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [37] Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
    Portacci, Andrea
    Campisi, Raffaele
    Buonamico, Enrico
    Nolasco, Santi
    Pelaia, Corrado
    Crimi, Nunzio
    Benfante, Alida
    Triggiani, Massimo
    Spadaro, Giuseppe
    Caiaffa, Maria Filomena
    Scioscia, Giulia
    Detoraki, Aikaterini
    Valenti, Giuseppe
    Papia, Francesco
    Tomasello, Alessandra
    Scichilone, Nicola
    Pelaia, Girolamo
    Crimi, Claudia
    Carpagnano, Giovanna Elisiana
    ERJ OPEN RESEARCH, 2023, 9 (05)
  • [38] Belgian real-world data confirm the potential of benralizumab to induce clinical remission in patients with severe eosinophilic asthma
    Dupont, Lieven
    Pilette, Charles
    Deschampheleire, Maud
    Eger, Katrien
    Martinot, Jean-Benoit
    Leys, Mathias
    Himpe, Ulrike
    Peche, Rudi
    Lins, Muriel
    Delovinfosse, Solange
    Simonis, Helene
    Herreman, An
    Quataert, Charlotte
    Feys, Tom
    Louis, Renaud
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [39] 3-year real world outcomes with benralizumab for severe eosinophilic asthma
    Palmer, H.
    Whitehurst, C.
    Hince, K.
    Khurana, S.
    Tavernier, G.
    Elsey, L.
    THORAX, 2023, 78 (SUPPL_4) : A274 - A275
  • [40] Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea
    Lee, Ji-Ho
    Lee, Hyun Young
    Jung, Chang-Gyu
    Ban, Ga-Young
    Shin, Yoo Seob
    Ye, Young-Min
    Nahm, Dong-Ho
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2018, 10 (02) : 121 - 130
12345